Therapy resistant hypertension - Significance of electronic compliance monitoring;Therapierefraktäre hypertonie - Stellenwert von elektronischem "compliance-monitoring"

Deutsche Medizinische Wochenschrift

Volumn 127, Issue 45, 2002, Pages 2379-2382

  Baulmann, J ^a   Dusing R ^a   Vetter, H ^a   Mengden, Thomas ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; HYDROCHLOROTHIAZIDE;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CASE REPORT; ELECTRONICS; FEMALE; GERIATRIC PATIENT; HUMAN; HYPERTENSION; MONITORING; PATIENT COMPLIANCE; SYSTOLIC BLOOD PRESSURE;

EID: 18744386383     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-35355     Document Type: Article

References (8)

1. Alderman MH, Budner N, Cohen H et al. Prevalence of drug resistant hypertension. Hypertension 1988; 11: 71-75
2. Andrejak M, Genes N, Vaur L et al. Electronic pill-boxes in the evaluation of antihypertensive treatment compliance: comparison of once daily versus twice daily regimen. Am J Hypertens 2000; 13: 184-190
3. Burnier M, Schneider MP, Chiolero A et al. Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J Hypertens 2001; 19: 335-341
4. Düsing R, Lottermoser K, Mengden T. Compliance with drug therapy-new answers to an old question. Nephrol Dial Transplant 2001; 16: 1317-1321
5. Guidelines Subcommittee. 1999 WHO-International Society of Hypertension Guidlines for the management of hypertension. J Hypertens 1999; 17: 151-183
6. Hasford J. Ausmaß und Folgen mangelhafter Compliance bei antihypertensiver Therapie. Herz/Kreisl 1999; 31 (Suppl 1); 15-19
7. Johnson BF, Hamilton G, Fink J et al. A design for resting interventions to improve adherence within a hypertension clinical trial. Control Clin Trials 2000; 21: 62-72
8. Mengden T, Binswanger B, Spuhler T et al. The use of self-measured blood pressure determinations in assessing dynamics of drug compliance in a study with amlodipine once a day, morning versus evening. J Hypertens 1993; 11: 1403-1411